Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA08.078c, Sebelipase alfa (Kanuma®)
Notification: 09/04/2018 | Effective: 12/03/2018 | Posted: 09/04/2018
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; General Description, Guidelines, or Informational Update


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA01.005b, Multiple Procedure Payment Reduction (MPPR) on Certain Diagnostic Services
Effective: 01/01/2017 | Posted: 09/07/2018
Type of policy change: Coverage and/or Reimbursement Position

MA07.035c, Transcranial Magnetic Stimulation (TMS)
Effective: 09/10/2018 | Posted: 09/10/2018
Type of policy change: Coverage and/or Reimbursement Position

MA07.004d, Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
Notification: 06/13/2018 | Effective: 09/10/2018 | Posted: 09/10/2018
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA11.058a, Otoplasty Otoplasty or Non-Surgical External Ear Molding
Notification: 06/12/2018 | Effective: 09/10/2018 | Posted: 09/10/2018
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

MA08.094b, Voretigene Neparvovec-rzyl (Luxturna™)
Effective: 09/24/2018 | Posted: 09/24/2018
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA10.007a, Speech Therapy
Effective: 01/01/2018 | Posted: 09/27/2018
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA06.021c, In Vitro Chemosensitivity and Chemoresistance Assays
Reissue Effective: 09/12/2018 | Reissue Posted: 09/12/2018

MA07.040a, Transcatheter Arterial Chemoembolization (TACE) of Hepatic Malignancies
Reissue Effective: 09/12/2018 | Reissue Posted: 09/12/2018

MA07.017b, Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Reissue Effective: 09/12/2018 | Reissue Posted: 09/12/2018

MA06.024, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Reissue Effective: 09/12/2018 | Reissue Posted: 09/12/2018

MA06.015c, AlloMap™ Molecular Expression Testing for Heart Transplant Rejection
Reissue Effective: 09/12/2018 | Reissue Posted: 09/12/2018

MA07.041a, Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic Malignancies
Reissue Effective: 09/12/2018 | Reissue Posted: 09/13/2018

MA08.012a, Off-label Coverage for Prescription Drugs and/or Biologics
Reissue Effective: 09/13/2018 | Reissue Posted: 09/13/2018

MA11.109a, Procedures for the Treatment of Acne
Reissue Effective: 09/12/2018 | Reissue Posted: 09/13/2018

MA08.061, Belatacept (Nulojix®)
Reissue Effective: 09/13/2018 | Reissue Posted: 09/13/2018

MA11.099a, Septoplasty, Rhinoplasty, and Septorhinoplasty
Reissue Effective: 09/26/2018 | Reissue Posted: 09/27/2018

MA11.073b, Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant Skin
Reissue Effective: 09/26/2018 | Reissue Posted: 09/27/2018

MA07.031, Laboratory-Based Vestibular Function Testing
Reissue Effective: 09/26/2018 | Reissue Posted: 09/27/2018

MA00.038a, Marijuana for Medical Use
Reissue Effective: 09/26/2018 | Reissue Posted: 09/27/2018

MA05.023a, Wheelchair Cushions and Seating
Reissue Effective: 09/27/2018 | Reissue Posted: 09/27/2018

MA08.044c, Eculizumab (Soliris®)
Reissue Effective: 09/27/2018 | Reissue Posted: 09/27/2018

MA05.026a, Manual Wheelchairs
Reissue Effective: 09/27/2018 | Reissue Posted: 09/27/2018

MA08.050, Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C®, Aralast NP™, Glassia™, Zemaira™)
Reissue Effective: 09/27/2018 | Reissue Posted: 09/27/2018


Archived Policies
Independence Blue Cross has determined that it is no longer necessary for the following Medicare Advantage policy to remain active.
MA09.019, Magnetic Resonance Imaging (MRI) for Monitoring the Integrity of Silicone-Gel-Filled Breast Implants in Asymptomatic Individuals
Notification: 09/28/2018 | Archive Effective: 10/29/2018 | Posted: 09/28/2018

(Not Categorized)
MA09.009i, Reimbursement for Diagnostic and Therapeutic Radiopharmaceutical Agents for Professional Providers
Effective: 09/24/2018 | Posted: 09/24/2018










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.